ストックスクリーナーアプリを入手
0.6235
2.15%
-0.0137
アフターアワーズ：
.65
0.0265
+4.25%
前日終値:
$0.6372
開ける：
$0.672
24時間の取引高:
1.44M
Relative Volume:
1.03
時価総額：
$75.00M
収益：
-
当期純損益:
$-93.61M
株価収益率:
-0.2955
EPS:
-2.11
ネットキャッシュフロー:
$-71.16M
1週間 パフォーマンス:
+22.21%
1か月 パフォーマンス:
-6.18%
6か月 パフォーマンス:
-14.26%
1年 パフォーマンス:
-42.80%
1日の値動き範囲:
$0.613
$0.6836
1週間の範囲:
$0.5092
$0.6836
52週間の値動き範囲:
$0.5062
$1.39
Immunic Inc Stock (IMUX) Company Profile
IMUX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.6235 | 76.65M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-07 | 開始されました | Roth Capital | Buy |
| 2025-09-29 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-25 | 開始されました | William Blair | Outperform |
| 2024-11-25 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
| 2024-08-27 | 開始されました | B. Riley Securities | Buy |
| 2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2021-04-15 | 開始されました | Aegis Capital | Buy |
| 2021-03-24 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-02 | 開始されました | SVB Leerink | Outperform |
| 2020-08-26 | 開始されました | Piper Sandler | Overweight |
| 2020-08-07 | 再開されました | ROTH Capital | Buy |
| 2020-07-20 | 開始されました | BMO Capital Markets | Outperform |
| 2020-06-05 | 開始されました | Wedbush | Outperform |
| 2020-05-11 | 開始されました | H.C. Wainwright | Buy |
| 2020-03-25 | 開始されました | ROTH Capital | Buy |
| 2019-07-11 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Immunic Inc (IMUX) 最新ニュース
Immunic Transfers Listing to Nasdaq Capital Market for Compliance - TipRanks
Immunic to transfer listing to Nasdaq Capital Market after bid price non-compliance - Investing.com
Immunic Announced Transfer or Voluntary Withdrawal of Listing - TradingView — Track All Markets
Immunic (NASDAQ:IMUX) Shares Up 9.3% – Should You Buy? - Defense World
Immunic appoints Duane Nash as CEO of new subsidiary Gliomic, updates executive agreements - Investing.com Australia
Immunic appoints Duane Nash as CEO of new subsidiary Gliomic, updates executive agreements By Investing.com - Investing.com South Africa
Immunic (IMUX) Has a New Rating from Chardan Capital - The Globe and Mail
Celiac Disease Market Report 2025-2035: Drivers, Challenges, Opportunities, Industry Trends and Case Studies - GlobeNewswire Inc.
Immunic Earnings Notes - Trefis
Gainers Report: Will Immunic Inc 10VA stock benefit from mergers2025 Fundamental Recap & Reliable Breakout Forecasts - moha.gov.vn
Will Immunic Inc. (10VA) stock benefit from mergersJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - Улправда
Will Immunic Inc. (10VA) stock extend growth storyWeekly Trade Summary & AI Based Buy/Sell Signal Reports - DonanımHaber
Why Immunic Inc. (10VA) stock stays resilientQuarterly Profit Review & Daily Chart Pattern Signals - DonanımHaber
Will Immunic Inc. stock outperform international peersStock Surge & Intraday High Probability Alerts - Улправда
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and Immunic (IMUX) - The Globe and Mail
Immunic Inc (IMUX)’s stock performance: a year in review - uspostnews.com
Immunic launches public offering of warrants to fund clinical trials; shares down - MSN
683 Capital Management LLC Reduces Stake in Immunic, Inc. $IMUX - Defense World
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of “Buy” by Analysts - Defense World
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Buy" by Analysts - MarketBeat
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Immunic Inc - GuruFocus
How does Immunic Inc (IMUX) change from a tortoise to a hare? - setenews.com
Immunic’s long-term treatment hope for multiple sclerosis – ICYMI - Proactive financial news
Operating income of Immunic, Inc. – HAM:10VA - TradingView
Will Immunic Inc. stock deliver better than expected guidanceRisk Management & Real-Time Buy Signal Alerts - Newser
How risky is Immunic Inc. stock nowJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will Immunic Inc. (10VA) stock return to pre crash levels2025 Fundamental Recap & Consistent Profit Alerts - Newser
How supply chain issues affect Immunic Inc. stockMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Why Immunic Inc. (10VA) stock is a strong analyst pickPortfolio Gains Summary & Technical Pattern Alert System - Newser
Can Immunic Inc. (10VA) stock withstand sector downturnsTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Is Immunic Inc. stock near bottom after declineOil Prices & Daily Momentum Trading Reports - Newser
How Immunic Inc. stock performs in stagflation2025 Investor Takeaways & Target Return Focused Picks - Newser
Immunic marks International Day of Persons with Disabilities with hope for MS sufferers - Proactive financial news
What consensus target says about Immunic Inc. (10VA) stockWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Why Immunic Inc. stock is considered a top pickPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Will Immunic Inc. (10VA) stock outperform Dow JonesTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
IMUX stock touches 52-week low at $0.92 amid market challenges - MSN
Will Immunic Inc. (10VA) stock outperform global peers2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Immunic (IMUX) Stock Analysis Report | Financials & Insights - Benzinga
B. Riley Has Bullish Estimate for Immunic FY2025 Earnings - MarketBeat
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - Sahm
What is B. Riley’s Forecast for Immunic FY2025 Earnings? - Defense World
What is B. Riley’s Estimate for Immunic Q1 Earnings? - Defense World
B. Riley Forecasts Immunic's Q1 Earnings (NASDAQ:IMUX) - MarketBeat
Immunic announces attendance at upcoming Evercore ISI Healthcare Conference | NASDAQ:IMUX - Proactive financial news
Immunic (NASDAQ: IMUX) to present at 8th Evercore ISI Healthcare Conference on Dec. 4 - Stock Titan
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Analysts Offer Predictions for Immunic FY2025 Earnings - MarketBeat
Immunic FY2025 EPS Boosted by Brookline Capital Management - MarketBeat
Immunic (NASDAQ:IMUX) Upgraded at Chardan Capital - Defense World
Immunic Inc. (IMUX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Immunic Inc (IMUX) 財務データ
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):